TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Spago Nanomedical AB (publ)
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 | 2021/12 |
| Turnover |
1,203
|
1,054
|
660 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-42,223
|
-39,197
|
-39,071 |
| EBITDA |
-42,792
|
-39,109
|
-38,816 |
| Total assets |
52,985
|
205,953
|
191,624 |
| Current assets |
51,907
|
65,243
|
54,387 |
| Current liabilities |
11,477
|
8,797
|
6,812 |
| Equity capital |
41,317
|
197,156
|
184,812 |
| - share capital |
18,859
|
90,944
|
41,182 |
| Employees (average) |
13
|
15
|
16 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
| Solvency |
78.0%
|
95.7%
|
96.4% |
| Turnover per employee |
93
|
70
|
41 |
| Profit as a percentage of turnover |
-3509.8%
|
-3718.9%
|
-5919.8% |
| Return on assets (ROA) |
-79.7%
|
-19.0%
|
-20.4% |
| Current ratio |
452.3%
|
741.7%
|
798.4% |
| Return on equity (ROE) |
-102.2%
|
-19.9%
|
-21.1% |
| Change turnover | |||
| Change turnover % |
60%
|
93% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
-6%
|
7% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.